================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.
----------------------------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) FEBRUARY 28, 2006
BIOSCRIP, INC.
(Exact Name of Registrant as Specified in its Charter)
DELAWARE 0-28740 05-0489664
(State or Other Jurisdiction of (Commission (IRS Employer
Incorporation) File Number) Identification No.)
100 CLEARBROOK ROAD, ELMSFORD, NEW YORK 10523
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code (914) 460-1600
------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Section Act (17 CFR
230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12).
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240-14d-2(b)).
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c)).
================================================================================
ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS;
APPOINTMENT OF PRINCIPAL OFFICERS.
On February 28, 2006, Mr. Richard A. Cirillo, a BioScrip, Inc. (the "Company")
director since April 1998, informed the Company's Executive Chairman that he was
resigning from the Company's Board of Directors. Mr. Cirillo has had no
disagreements with Company with respect to any matters.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned duly authorized.
Date: March 6, 2006 BIOSCRIP, INC.
By: /s/ Barry A. Posner
-----------------------------------
Barry A. Posner,
Executive Vice President, Secretary
and General Counsel
2